NCT00717288View on ClinicalTrials.gov

Transitioning Open Heart Surgery Patients From Insulin Infusions to Detemir

PHASE4CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

March 31, 2010

Study Completion Date

June 30, 2010

Conditions
Diabetes Mellitus
Interventions
DRUG

Detemir

Detemir dosed at 50% of calculated basal insulin infusion requirements

DRUG

Detemir

Detemir dosed at 65% of calculated basal insulin infusion requirements

DRUG

Detemir

Detemir dosed at 80% of calculated basal insulin infusion requirements

Trial Locations (1)

43210

The Ohio State University, Columbus

Sponsors

Collaborators (1)

Novo Nordisk A/S
All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

Ohio State University

OTHER